We are live on ! Find out more
BBLGW

Bone Biologics Corp Warrants
BBLGW

4 hedge funds and large institutions have $246K invested in Bone Biologics Corp Warrants in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
+4
Holders Change %
–
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$138K
2
WAM
Warberg Asset Management
Illinois
+$32.4K
3
UBS Group
UBS Group
Switzerland
+$3.82K

Top Sellers

No sellers this quarter

BBLGW Hedge Fund Activity: Q4 2021 in Review

4 of the 6,519 institutional investors tracked by Wall St. Rank reported a position in Bone Biologics Corp Warrants (BBLGW) for Q4 2021, worth a combined $246K.

Buyers outnumbered sellers: 4 funds opened new BBLGW positions and 0 closed out — a net gain of 4 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $138K.

  • 4 institutional investors held Bone Biologics Corp Warrants (BBLGW) as of Q4 2021, up from 0 in Q3 2021.
  • Funds reported $246K of Bone Biologics Corp Warrants stock for Q4 2021.
  • 4 funds opened new Bone Biologics Corp Warrants positions in Q4 2021 and 0 closed out, a net change of +4 holders.
  • The largest Bone Biologics Corp Warrants buyer in Q4 2021 was Sabby Management, an estimated $138K added.

Based on aggregated 13F filings for Q4 2021.